Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Paolo
Feb 28, 2024, 12:04 |
Blog
Paolo Tarantino: Always impressed by the impact my stellar mentor had on the lives of patients and of dozens of mentees
Paolo Tarantino, Clinical research fellow in the Breast Oncology Program at the Dana-Farber Cancer Institute,…
Feb 27, 2024, 15:23 |
Blog
Paolo Tarantino: Great JSMO24 session on HR+ MBC
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, recently posted on X/Twitter: "Great JSMO24…
Feb 26, 2024, 19:24 |
Blog
Paolo Tarantino: True honour to have the opportunity of joining the outstanding faculty of JSMO24 to review
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post by…
Feb 19, 2024, 07:17 |
Career
Paolo Tarantino: Honored to be awarded a Terri Brodeur Foundation 2024 Grant
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared on X/Twitter: "Honored…
Feb 18, 2024, 10:00 |
Blog
Paolo Tarantino: How do SONIA and NATALEE impact our use of CDK4/6-inhibitors
Paolo Tarantino, Medical Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared a post on X/Twitter: “How…
Feb 15, 2024, 18:33 |
Blog
Paolo Tarantino: So glad to join outstanding colleagues and friends for productive discussions on the evolving treatment landscape for breast cancer at JSMO24
Paolo Tarantino, Medical Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared an X post by Kazuki…
Feb 12, 2024, 15:36 |
Blog
Paolo Tarantino: Important update of the ABC trials
Paolo Tarantino, Medical Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared a post on X/Twitter: "Important…
Feb 11, 2024, 15:45 |
Blog
Paolo Tarantino: In a large RW cohort we found that nearly 30% of breast tumors changed HER2 status after neoadjuvant treatment
Paolo Tarantino, Medical Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared a post on X/Twitter: “In…
Feb 10, 2024, 08:06 |
Insight
Paolo Tarantino: Final OS from BROCADE3 phase 3 trial
Paolo Tarantino, Medical Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared a post on X/Twitter: "Final…
Feb 8, 2024, 17:54 |
Insight
Paolo Tarantino: Few treatments in oncology allow to achieve more than 50% intracranial response rates, with durable efficacy
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared ESMO Open's post on X/Twitter, adding: "One…
10
11
12
13
14
All:
264
Posts:
111 - 120
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube